-
公开(公告)号:EP1414462A4
公开(公告)日:2004-08-18
申请号:EP02735929
申请日:2002-05-23
发明人: NAGLER ARNON , VLODAVSKY ISRAEL , PINES MARK , YARKONI SHAI
IPC分类号: A61J1/03 , A61K9/08 , A61K9/10 , A61K9/14 , A61K9/16 , A61K9/20 , A61K9/48 , A61K31/495 , A61K31/517 , A61P3/10 , A61P9/12 , A61P13/12 , A61P37/06 , C07D401/06 , A61K31/505 , A61P43/00
CPC分类号: A61K31/495
-
2.QUINAZOLINONE COMPOSITIONS FOR REGULATION OF GENE EXPRESSION RELATED TO PATHOLOGICAL PROCESSES 审中-公开
标题翻译: 喹唑啉酮成分ZURREGULIERUNG基因表达的病理过程CONNECTION公开(公告)号:EP1558261A4
公开(公告)日:2008-06-04
申请号:EP03769875
申请日:2003-10-30
发明人: PINES MARK , NAGLER ARNON , YARKONI SHAI , VLODAVSKI ISRAEL
IPC分类号: A61K20060101 , A61K31/517
CPC分类号: A61K31/517
-
3.QUINAZOLINONE COMPOUNDS IN COMBINED MODALITIES FOR IMPROVED CANCER TREATMENT 审中-公开
标题翻译: QUINAZOLINONVERBINDUNGEN,在混合应用改进癌症治疗公开(公告)号:EP1465633A4
公开(公告)日:2007-02-21
申请号:EP02806385
申请日:2002-12-30
发明人: VLODAVSKY ISRAEL , NAGLER ARNON PROF , YARKONI SHAI , PINES MARK
IPC分类号: C07D401/06 , A61K31/131 , A61K31/138 , A61K31/167 , A61K31/17 , A61K31/196 , A61K31/198 , A61K31/282 , A61K31/337 , A61K31/407 , A61K31/4164 , A61K31/4745 , A61K31/475 , A61K31/513 , A61K31/517 , A61K31/519 , A61K31/52 , A61K31/57 , A61K31/675 , A61K31/704 , A61K31/7048 , A61K31/7068 , A61K33/24 , A61K38/00 , A61K38/04 , A61K38/21 , A61K38/43 , A61K45/00 , A61K45/06 , A61P35/00 , A61P43/00 , C07D239/88
CPC分类号: A61K45/06 , A61K31/517 , A61K2300/00
-
4.STABILIZED PHARMACEUTICAL COMPOSITIONS OF HALOFUGINONE AND OTHER QUINAZOLINONE DERIVATIVES 审中-公开
标题翻译: 常山酮和其他衍生稳定的药物组合物喹唑啉酮公开(公告)号:EP1482942A4
公开(公告)日:2010-11-03
申请号:EP03703004
申请日:2003-02-19
发明人: YARKONI SHAI , ZELIKOVICH LIOR
IPC分类号: A61K9/20 , C07D401/06 , A61K9/00 , A61K9/06 , A61K9/08 , A61K9/10 , A61K9/107 , A61K9/127 , A61K9/14 , A61K9/16 , A61K31/505 , A61K31/517 , A61K47/00 , A61K47/06 , A61K47/10 , A61K47/12 , A61K47/14 , A61K47/26 , A61K47/34 , A61K47/36 , A61K47/38 , A61K47/42 , A61K47/44 , A61P1/16 , A61P11/00 , A61P13/12 , A61P17/00
CPC分类号: A61K9/0014 , A61K9/0019 , A61K9/2013 , A61K31/517 , A61K47/12
-
-
-